NUCALA 100 MG/ML SOL INJ CT SER PREENC VD TRANS + ADAPT + AGU
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1010703350024 -
GGREM
510620110056307 -
Código de barras
7896015591991
O que a fonte publica
- Detentor do registro
- GLAXOSMITHKLINE BRASIL LTDA
- Princípios ativos
- MEPOLIZUMABE
- Embalagem
- 100 MG/ML SOL INJ CT SER PREENC VD TRANS + ADAPT + AGU
- Regime de dispensação
- Tarja Vermelha
- Tipo de produto
- Biológico
- Classe terapêutica
- R3M - ANTIASMÁTICOS INIBIDORES DA INTERLEUCINA
- Prescrição
- Sob prescrição ou restrito
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "NUCALA 100 MG/ML SOL INJ CT SER PREENC VD TRANS + ADAPT + AGU",
"holder": "GLAXOSMITHKLINE BRASIL LTDA",
"stripe": "Tarja Vermelha",
"barcodes": [
"7896015591991",
"0000000000000"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "510620110056307",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "33.247.743/0001-10",
"priceRegime": "Regulado",
"productName": "NUCALA",
"productType": "Biológico",
"hospitalOnly": false,
"presentation": "100 MG/ML SOL INJ CT SER PREENC VD TRANS + ADAPT + AGU",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha",
"factoryPrices": {
"icms-0": "8374.55",
"icms-12": "9516.54",
"icms-17": "10089.82",
"icms-18": "10212.86",
"icms-19": "10338.95",
"icms-20": "10468.19",
"icms-21": "10600.70",
"icms-22": "10736.60",
"icms-23": "10876.04",
"icms-17.5": "10150.97",
"icms-19.5": "10403.17",
"icms-20.5": "10534.03",
"icms-22.5": "10805.87",
"icms-12-alc": "8496.91",
"icms-17-alc": "9008.76",
"icms-18-alc": "9118.63",
"icms-19-alc": "9231.20",
"icms-20-alc": "9346.59",
"icms-21-alc": "9464.91",
"icms-22-alc": "9586.25",
"icms-23-alc": "9710.74",
"withoutTaxes": "7477.28",
"icms-17.5-alc": "9063.37",
"icms-19.5-alc": "9288.54",
"icms-20.5-alc": "9405.37",
"icms-22.5-alc": "9648.09"
},
"pisCofinsList": "Negativa",
"substanceText": "MEPOLIZUMABE",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "11234.16",
"icms-12": "12766.10",
"icms-17": "13535.13",
"icms-18": "13700.19",
"icms-19": "13869.33",
"icms-20": "14042.70",
"icms-21": "14220.46",
"icms-22": "14402.77",
"icms-23": "14589.82",
"icms-17.5": "13617.16",
"icms-19.5": "13955.48",
"icms-20.5": "14131.03",
"icms-22.5": "14495.69",
"icms-12-alc": "11746.48",
"icms-17-alc": "12454.08",
"icms-18-alc": "12605.97",
"icms-19-alc": "12761.59",
"icms-20-alc": "12921.11",
"icms-21-alc": "13084.68",
"icms-22-alc": "13252.43",
"icms-23-alc": "13424.53",
"withoutTaxes": "10336.89",
"icms-17.5-alc": "12529.58",
"icms-19.5-alc": "12840.86",
"icms-20.5-alc": "13002.37",
"icms-22.5-alc": "13337.92"
},
"invalidBarcodes": [
"0000000000000"
],
"activeSubstances": [
"MEPOLIZUMABE"
],
"therapeuticClass": "R3M - ANTIASMÁTICOS INIBIDORES DA INTERLEUCINA",
"commercialisation": {
"year": 2025,
"marketed": false
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1010703350024",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "R3M",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:510620110056307"